Early renal damage assessed by the SLICC/ACR damage index is predictor of severe outcome in lupus patients in Pakistan

Lupus

Volumn 19, Issue 13, 2010, Pages 1573-1578

  Rabbani, M A ^a   Habib, H B ^b   Islam, M ^b   Ahmad, B ^b   Shah, S M A ^b   Tahir, S ^c   Merchant, D ^a   Ahmad, A ^a  

^a Kidney Centre Karachi   (Pakistan)

^b AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^c JINNAH SINDH MEDICAL UNIVERSITY   (Pakistan)

Author keywords

mortality; organ damage; SLE

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL; HUMAN; KAPLAN MEIER METHOD; KIDNEY INJURY; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PAKISTAN; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PAKISTAN; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 78649280632     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310375704     Document Type: Article

References (31)

1. Ippolito A., Petri M. An update on mortality in SLE. Clin Exp Rheumatol 2008 ; 26: 72-79.
2. Merrell M., Shulman LE Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chronic Dis 1955 ; 1: 12-32.
3. Gripenberg M., Helve T. Outcome of systemic lupus erythematosus: a study of 66 patients over 7 years with special reference to the predictive value of anti-dsDNA antibody determination. Scand J Rheumatol 1991 ; 20: 104-109.
4. Pistiner M., Wallace DJ, Nessim S., Metzger A. l, Klineberg JR Lupus erythematosus in the 1980g's: a survey of 570 patients. Semin Arthritis Rheum 1991 ; 21: 55-64.
5. Ward MM, Pyun E., Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 1996 ; 156: 1337-1344.
6. Rabbani MA, Habib HB, Islam M., et al. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients. Lupus 2009 ; 18: 848-855.
7. Rabbani MA, Tahir MH, Siddiqui BK, Ahmad B., Shamim A., Shah SM, Ahmad A. Lupus in Pakistan. Lupus 2005 ; 13: 820-825.
8. Nossent JC Course and prognosis of systemic lupus erythematosus disease activity in Black Caribbean patients. Semin Arthritis Rheum 1993 ; 23: 16-21.
9. Lopez-Acuna D., Hochberg M., Gittelsohn A. Do persons of Spanish heritage have an increased mortality from systemic lupus erythematosus compared to other Caucasians? Arthritis Rheum 1982 ; 25: S67.
10. Gladman D., Ginzlcr E., Goldsmith C., et al. Systemic lupus international collaborative clinics: development of a damage index in systemic lupus erythematosus. J Rheumatol 1992 ; 19: 1820-1821.
11. Gladman D., Goldsmith C., Urowitz M., et al. Derivation of a weighting scale for the SL1CC/ACR damage index - preliminary results. Arthritis Rheum 1994 ; 37 (Suppl 9). S326.
12. Karlson EW, Daltroy LH, Lew RA, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997 ; 40: 47-56.
13. Zonana-Nacach A., Camargo-Coronel A., Yaäez P., et al. Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration. Lupus 1998 ; 7: 119-123.
14. Stoll T., Seifert B., Isenberg DA SLICC/ACR damage index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 1996 ; 35: 248-254.
15. Becker-Merok A., Nossent HC Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality. J Rheumatol 2006 ; 33: 1570-1577.
16. Andrade RM, Alarcón GS, Fernández M., et al. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. Arthritis Rheum 2007 ; 56: 622-630.
17. Gladman DD, Goldsmith CH, Urowitz MB, et al. Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: international validation. J Rheumatol 1994 ; 21: 1468-1471.
18. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982 ; 25: 1271-1277.
19. Petri M., Barr SG, Zonana-Nacach A., Magder L. Measures of disease activity, damage, and health status: the Hopkins Lupus Cohort experience. J Rheumatol 1999 ; 26: 502-503.
20. Levey AS, Lan SP, Corwin HL, et al. Progression and remission of renal disease in the lupus nephritis collaborative study. Ann Intern Med 1992 ; 11: 114-123.
21. Esdaile JM, Abrahamowicz M., MacKenzie T., Hayslett JP, Kashgarian M. The time-dependence of long-term prediction in lupus nephritis. Arthritis Rheum 1994 ; 37: 359-368.
22. Weinrib L., Sharma OP, Quismorio Jr FP A long-term study of interstitial lung disease in systemic lupus erythematosus. Semin Arthritis Rheum 1990 ; 20: 48-56.
23. Guillevin L. Vasculopathy and pulmonary arterial hypertension. Rheumatology (Oxford) 2009 ; 48 (Suppl 3). iii54-57.
24. Reveille JD, Bartolucci A., Alarcon GS Prognosis in SLE. Negative impact of increasing age at onset, black race and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990 ; 33: 37-48.
25. Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Arch Intern Med 1990 ; 150: 849-853. (Pubitemid 20122062)
26. Hochberg MC, Boyd RE, Ahearn JM, et al. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine 1985 ; 64: 285-295.
27. Alarcon GS, McGwin Jr.G., Petri M., et al. Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. PLoS Med 2006 ; 3: e396.
28. Wallace DJ The clinical presentation of SLE. In: Wallace DJ, Hahn BH (eds), Duboisg' lupus erythematosus, 4 th edn. Philadelphia and London: Lea and Febiger ; 1993. p. 317-321.
29. Arnett FC Genetic studies of human lupus in families. Int Rev Immunol 2000 ; 194: 297-317.
30. Hakim A. Comments on 'consanguineous marriages in Pakistang'. Pak Dev Rev 1994 ; 33: 675-676.
31. Afzal M., Ali SM, Siyal HB Consanguineous marriages in Pakistan. Pak Dev Rev 1994 ; 33: 663-674.